Claudin18.2 bispecific T cell engager armed oncolytic virus enhances antitumor effects against pancreatic cancer.
Liu S, Li F, Deng L, Ma Q, Lu W, Zhao Z, Liu H, Zhou Y, Hu M, Wang H, Yan Y, Zhao M, Zhang H, Du M.
Liu S, et al. Among authors: zhao z, zhao m.
Mol Ther Oncolytics. 2023 Aug 24;30:275-285. doi: 10.1016/j.omto.2023.08.011. eCollection 2023 Sep 21.
Mol Ther Oncolytics. 2023.
PMID: 37701851
Free PMC article.